This study is evaluating whether a combination of two drugs may help treat mantle cell lymphoma in elderly patients.
2 Primary · 3 Secondary · Reporting Duration: Up to 7 years
Experimental Treatment
50 Total Participants · 1 Treatment Group
Primary Treatment: Acalabrutinib · No Placebo Group · Phase 2
Age 65+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: